USP8 and neoplasm: Our results indicated that knockdown of USP8 or administration of erastin significantly inhibited tumor growth in vivo, erastin treatment and USP8 depletion in combination significantly inhibited tumor growth in vivo than administration of erastin or USP8 depletion alone (Fig. 5L).